INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT)

NANot yet recruitingINTERVENTIONAL
Enrollment

2,500

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Unruptured Intracranial AneurysmIndobufen
Interventions
DRUG

Indobufen treatment

Patients in the experimental group will be required to take indobufen (100 mg twice daily) + clopidogrel (75 mg once daily) starting 5 days before the procedure and continuing until 180 days postoperatively.

DRUG

Aspirin treatment

Patients in the control group will be required to take aspirin (100 mg once daily) + clopidogrel (75 mg once daily) starting 5 days before the procedure and continuing until 180 days postoperatively.

All Listed Sponsors
collaborator

RenJi Hospital

OTHER

collaborator

First Affiliated Hospital of Fujian Medical University

OTHER

collaborator

Jiangnan University Central Hospital

UNKNOWN

collaborator

Beijing Chao Yang Hospital

OTHER

collaborator

Beijing Friendship Hospital

OTHER

collaborator

Beijing Shuyi Hospital

OTHER

collaborator

The Central Hospital of Lishui City

OTHER

lead

Beijing Tiantan Hospital

OTHER

NCT07089862 - INdobufen Versus asPirin in Endovascular Unruptured Intracranial Aneurysms Treatment (INPUT) | Biotech Hunter | Biotech Hunter